[1] Crabb DW, Im GY, Szabo G,et al. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology,2020,71(1):306-333.
[2] Degré D, Stauber RE, Englebert G,etal.Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey′s discriminant function<32. J Hepatol,2020,72(4): 636-642.
[3] Adejumo AC, Cholankeril G, Iqbal U, etal.Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci,2020,65(4): 990-1002.
[4] 中华医学会,中华医学会杂志社,中华医学会消化病学分会,等.酒精性肝病基层诊疗指南(2019年).中华全科医师杂志,2020,19(11):990-996.
[5] Rana R, Wang SL, Li J, et al. A prognostic evaluation and management of alcoholic hepatitis. Minerva Med,2017,108(6):554-567.
[6] Suzuki Y, Kakisaka K, Suzuki A,et al. A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients. Hepatol Res,2019,49(7): 758-764.
[7] Noronha L, FitzGerald E, Pierce JR Jr. Outcomes of Patients Hospitalized for Severe Acute Alcoholic Hepatitis. South Med J,2019,112(7): 363-368.
[8] 中华医学会外科学分会胰腺外科学组.中国急性胰腺炎诊治指南( 2021).中华外科杂志,2021,59(7): 578-587. |
